Marc Hilmi (@MarcHilmi)

2026.10.25 14:56

Grateful to present 3 posters at #ESMO2026# in Madrid! 🇪🇸 1. Pathogenic germline ATM alterations define a distinct pancreatic cancer subtype with improved survival, less liver metastases and reduced KRAS signaling. @CentralParkWMD @EileenMOReilly @ciacobu @CpcrMsk 2. POSTN+ fibroblasts identify an aggressive tumor microenvironment and poorer survival in pancreatic cancer (#PRODIGE24#). @RemyNicolle @cros_jerome 3. Early CT-derived body composition changes predict survival in biliary tract cancer patients receiving immunotherapy, independently of radiological progression, CA19-9, ECOG PS, and weight loss (#PRODIGE57#). @DelayeMatthieu Grateful to all collaborators at @MSKCancerCenter, @institut_curie, and GERCOR/PRODIGE! #PancreaticCancer# #GIOncology#

Forward to community